SHB 2122
In CommitteeHouse
Hospital influenza imm.
Requiring hospitals to offer immunizations for influenza in certain cases.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill requires Washington hospitals to offer flu shots to older and medically vulnerable inpatients during flu season. It aims to protect high-risk patients by making flu prevention part of routine hospital care.
- Starting October 1, 2027, hospitals must offer influenza immunizations to inpatients aged 65 or older and inpatients of any age with one or more chronic health conditions.
- Offers are only required during flu season (October 1 through March 1) each year.
- Hospitals must follow CDC recommendations from the Advisory Committee on Immunization Practices (ACIP) and can only offer the vaccine if it is available and medically appropriate (i.e., not contraindicated for the patient).
- The Washington State Department of Health may write rules to implement the law.
- The requirement applies to all hospitals in Washington, regardless of size or type.
Who is affected
- Older adults (65+) — Hospital inpatients aged 65 or older will be offered flu shots during hospital stays, if medically appropriate and vaccine is available.
- People with chronic health conditions — Hospital inpatients of any age with chronic health conditions (like heart disease, diabetes, or lung disease) will be offered flu shots during hospital stays, if medically appropriate and vaccine is available.
- Hospitals — Hospitals across Washington must develop systems to identify eligible patients and offer flu immunizations during flu season (October 1–March 1), following CDC guidance and vaccine availability.
- Washington State Department of Health — The Washington State Department of Health will oversee implementation, including writing rules to carry out the law.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (4)
Directly improves health outcomes for high-risk patients—older adults (65+) and those with chronic conditions—by reducing influenza-related hospitalizations, complications, and mortality during inpatient stays.
HealthcarePeopleRef: Sec. 1(1)Aligns hospital practices with CDC/ACIP evidence-based guidance, strengthening herd immunity and reducing community flu transmission, especially during seasonal surges.
Public SafetyPeopleRef: Sec. 1(2)(b)Reduces long-term healthcare costs by preventing flu-related complications (e.g., pneumonia, exacerbations of chronic conditions), potentially lowering readmission rates and downstream Medicaid/Medicare spending.
HealthcarePeopleRef: Sec. 1(1)Empowers the Department of Health to ensure consistent, equitable implementation across hospitals via rulemaking, supporting standardized care and monitoring.
Public SafetyPeopleRef: Sec. 1(3)
Potential Concerns (1)
Hospitals may face operational and financial burdens implementing the mandate without state funding, potentially diverting staff time and resources from other clinical priorities—especially smaller or under-resourced hospitals.
HealthcarePeopleRef: Sec. 1(1), (2)(a)
Who Is Most Affected
Older inpatients and those with chronic conditions are directly protected from a preventable, potentially life-threatening illness during vulnerable hospital stays. This group has high flu-related hospitalization and death rates, and the policy targets them specifically.
Hospitals—especially small, rural, or safety-net facilities—may face added administrative and staffing costs (e.g., vaccine procurement, staff training, documentation) without reimbursement or state funding, though burden may be modest given the seasonal, time-limited scope.
The Department of Health gains authority to implement and enforce the law via rulemaking, strengthening its role in public health preparedness—but no additional funding is provided, limiting capacity unless reallocated.
Vaccine manufacturers may see modest demand increases during hospital flu season, but the policy does not mandate purchase or set pricing—impact is likely negligible compared to broader public health programs.
Insurance payers (Medicare, Medicaid, commercial insurers) may benefit indirectly from reduced complications and readmissions, lowering per-member-per-month costs—though they bear no direct obligation under the bill.